Kip, Anke E
609  Ergebnisse:
Personensuche X
?
2

Low antileishmanial drug exposure in HIV-positive visceral ..:

Kip, Anke E ; Blesson, Séverine ; Alves, Fabiana...
Journal of Antimicrobial Chemotherapy.  76 (2021)  5 - p. 1258-1268 , 2021
 
?
3

Blood Parasite Load as an Early Marker to Predict Treatment..:

Verrest, Luka ; Kip, Anke E ; Musa, Ahmed M...
Clinical Infectious Diseases.  73 (2021)  5 - p. 775-782 , 2021
 
?
4

Characterizing the non-linear pharmacokinetics of miltefosi..:

Palić, Semra ; Kip, Anke E ; Beijnen, Jos H...
Journal of Antimicrobial Chemotherapy.  75 (2020)  11 - p. 3260-3268 , 2020
 
?
5

Macrophage Activation Marker Neopterin: A Candidate Biomark..:

Kip, Anke E. ; Wasunna, Monique ; Alves, Fabiana...
Frontiers in Cellular and Infection Microbiology.  8 (2018)  - p. , 2018
 
?
7

Simultaneous population pharmacokinetic modelling of plasma..:

Kip, Anke E ; Castro, María del Mar ; Gomez, Maria Adelaida...
Journal of Antimicrobial Chemotherapy.  73 (2018)  8 - p. 2104-2111 , 2018
 
?
9

Visceral leishmaniasis relapse hazard is linked to reduced ..:

Dorlo, Thomas P C ; Kip, Anke E ; Younis, Brima M...
Journal of Antimicrobial Chemotherapy.  72 (2017)  11 - p. 3131-3140 , 2017
 
?
 
?
 
?
 
1-15